Position in NVCR
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$17,489,629
+$16,009,508 QoQ
Shares Held
1,154,431
+8960.8% QoQ
Ownership
0.991%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#17
of 214 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $93,312,876 across 21 Medical Devices names. NVCR ranks #1 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVCR |
NovoCure Ltd
This page
|
1,154,431 | $17,489,629 | |
| 2 | ABT |
Abbott Laboratories
|
166,065 | $15,068,733 | |
| 3 | MDT |
Medtronic plc
|
162,087 | $12,680,060 | |
| 4 | SYK |
Stryker Corp
|
28,726 | $9,044,091 | |
| 5 | AHCO |
AdaptHealth Corp.
|
646,861 | $6,740,291 | |
| 6 | BSX |
Boston Scientific Corp
|
114,625 | $4,892,191 | |
| 7 | QDEL |
QuidelOrtho Corp
|
267,989 | $4,695,167 | |
| 8 | EW |
Edwards Lifesciences Corp
|
43,120 | $3,900,633 |
All Filings in NVCR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,489,629 | 1,154,431 | Shares | Sole | 2026-08-17 | |
| 2021-09-30 | $1,480,121 | 12,741 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,108,177 | 9,504 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $931,985 | 13,840 | Shares | Sole | 2020-07-16 | |
| No filing history on record for this holder in this stock. | ||||||